Morgan Stanley cuts flatexDEGIRO stock rating to Equal-weight

Morgan Stanley downgraded flatexDEGIRO AG (FTKn:GR) from Overweight to Equal-weight, while raising the price target to EUR27.00 from EUR22.50. The revision reflects expectations of near-term transactional activity and solid core growth driven by new products and geographic expansion. However, the firm suggests the current valuation already reflects much of the company's growth potential, limiting further upside.

Analysis

Morgan Stanley has recalibrated its stance on flatexDEGIRO AG (FTKn:GR), downgrading the online brokerage's stock from Overweight to Equal-weight, while simultaneously increasing the price target to EUR27.00 from the previous EUR22.50. This revision is rooted in an analysis of earnings projections for 2025-2027, which indicates expectations for short-term benefits from heightened transactional activity and solid core growth in the medium term, driven by new product introductions and geographical expansion. Despite these positive operational forecasts, Morgan Stanley's assessment, reflected in a "Mixed Neutral" sentiment and a "cautious" tone, suggests that flatexDEGIRO's current share valuation already substantially prices in much of this anticipated growth. Consequently, the analysts perceive limited further upside for the stock price, leading to the Equal-weight rating, even as the increased price target acknowledges the firm's underlying potential to grow. This update provides a nuanced perspective on flatexDEGIRO's market position as investors continue to scrutinize the variable performance across the online brokerage sector.

Key Decisions for Investors

• Investors should acknowledge that while flatexDEGIRO's operational outlook and Morgan Stanley's price target of EUR27.00 are constructive, the downgrade to Equal-weight implies the stock is currently perceived as fairly valued, suggesting limited near-term alpha.
• Consider maintaining existing long positions if the investment horizon aligns with the medium-term growth catalysts, such as new product rollouts and geographic expansion, but exercise caution regarding new investments until either a more attractive valuation emerges or further positive catalysts materialize.
• Monitor the company's execution on its strategic initiatives, particularly the introduction of new products and success in geographical expansion, as these are critical to achieving the projected core growth and validating the EUR27.00 price target.